| Trademark Snap Shot Amendment & Mail Processing Stylesheet (Table presents the data on Amendment & Mail Processing Complete) |
|||
OVERVIEW |
|||
| SERIAL NUMBER | 90302923 | FILING DATE | 11/06/2020 |
| REG NUMBER | 0000000 | REG DATE | N/A |
| REGISTER | PRINCIPAL | MARK TYPE | TRADEMARK |
| INTL REG # | N/A | INTL REG DATE | N/A |
| TM ATTORNEY | MARTIN, CHRISTINE C |
L.O. ASSIGNED | 104 |
PUB INFORMATION |
|||
| RUN DATE | 07/30/2021 | ||
| PUB DATE | N/A | ||
| STATUS | 661-RESPONSE AFTER NON-FINAL-ACTION-ENTERED | ||
| STATUS DATE | 07/29/2021 | ||
| LITERAL MARK ELEMENT | EUROAPI | ||
| DATE ABANDONED | N/A | DATE CANCELLED | N/A |
| SECTION 2F | NO | SECTION 2F IN PART | NO |
| SECTION 8 | NO | SECTION 8 IN PART | NO |
| SECTION 15 | NO | REPUB 12C | N/A |
| RENEWAL FILED | NO | RENEWAL DATE | N/A |
| DATE AMEND REG | N/A | ||
FILING BASIS |
|||||
| FILED BASIS | CURRENT BASIS | AMENDED BASIS | |||
| 1 (a) | NO | 1 (a) | NO | 1 (a) | NO |
| 1 (b) | YES | 1 (b) | YES | 1 (b) | NO |
| 44D | YES | 44D | NO | 44D | NO |
| 44E | NO | 44E | YES | 44E | NO |
| 66A | NO | 66A | NO | ||
| NO BASIS | NO | NO BASIS | NO | ||
MARK DATA |
|
| STANDARD CHARACTER MARK | YES |
| LITERAL MARK ELEMENT | EUROAPI |
| MARK DRAWING CODE | 4-STANDARD CHARACTER MARK |
| COLOR DRAWING FLAG | NO |
CURRENT OWNER INFORMATION |
|
| PARTY TYPE | 10-ORIGINAL APPLICANT |
| NAME | Sanofi |
| ADDRESS | 54, rue La Boétie Paris, 75008 |
| ENTITY | 03-CORPORATION |
| CITIZENSHIP | France |
GOODS AND SERVICES |
|
| INTERNATIONAL CLASS | 001 |
| DESCRIPTION TEXT | Chemicals for use in industry and science |
| INTERNATIONAL CLASS | 005 |
| DESCRIPTION TEXT | Pharmaceutical preparations for the treatment of cardiovascular diseases, central and peripheral nervous system diseases, respiratory diseases, cancer, allergies, gynecological diseases, rheumatic diseases, urological diseases, gastroenterological diseases, infectious diseases, eye disease, dermatological diseases, autoimmune diseases, blood diseases, genital diseases, endocrine diseases, intestinal diseases, internal medicine diseases; hormones; vitamins; dietetic foods adapted for medical use; bacterial preparations for medical and veterinary use; disinfectants for hygienic purposes; medicated supplements for foodstuffs for medical or veterinary use; dietetic foods and beverages adapted for veterinary and medical use; food supplements for human beings and animals; disinfectants; biochemicals, namely, monoclonal antibodies for pharmaceutical use |
| INTERNATIONAL CLASS | 040 |
| DESCRIPTION TEXT | Treatment of chemicals, namely, custom manufacture and custom synthesis of pharmaceuticals and active pharmaceutical ingredients; Technical and scientific services, namely, providing technical information in the field of pharmaceutical manufacturing |
| INTERNATIONAL CLASS | 042 |
| DESCRIPTION TEXT | Research and development services in the field of health and biotechnologies, namely, research in the area of the development of new active elements; research in the area of a means of synthesis in the field of pharmaceutical products; scientific study and research in the area of industrial quality; development of methods of analysis for chemical and pharmaceutical products and bioorganics; development and studies of analytical methods checking chemical reactions; Scientific and technological services, namely, consulting and assistance in the research and development of pharmaceuticals; scientific and technical services, namely, scientific analysis of industrial installations; scientific research and development services in the field of pharmaceuticals; scientific research and development services for chemicals for the products of third parties, namely, the scientific and technical development of synthetic processes in the field of chemistry and biochemistry; scientific research and scientific and technical development in the field of pharmaceutical, chemical, agrochemical and industrial processes; scientific services, namely, scientific research and industrial analysis in the field of pharmaceuticals, chemicals, and agrochemical and industrial processes; scientific services, namely, scientific analysis allowing the identification and physical characterization of chemical molecules; scientific and technological services, namely, applied scientific research and development services, namely, conception of development or commercial batches for third parties in the fields of pharmaceuticals and chemicals; formulation and pre-formulation process design for pharmaceutical, chemical or agrochemical products; engineering services, namely, formulation, process evaluation and project management in the scientific and industrial fields, mainly in the chemical and pharmaceutical fields; engineering services for chemical and organic products and the processing thereof in the field of basic and industrial technology; scientific and technological services, namely, consulting and assistance in the research and development of chemicals and pharmaceuticals, including experimental and production processes and installations |
GOODS AND SERVICES CLASSIFICATION |
|||||||
| INTERNATIONAL CLASS | 001 | FIRST USE DATE | NONE | FIRST USE IN COMMERCE DATE | NONE | CLASS STATUS | 6-ACTIVE |
| INTERNATIONAL CLASS | 005 | FIRST USE DATE | NONE | FIRST USE IN COMMERCE DATE | NONE | CLASS STATUS | 6-ACTIVE |
| INTERNATIONAL CLASS | 040 | FIRST USE DATE | NONE | FIRST USE IN COMMERCE DATE | NONE | CLASS STATUS | 6-ACTIVE |
| INTERNATIONAL CLASS | 042 | FIRST USE DATE | NONE | FIRST USE IN COMMERCE DATE | NONE | CLASS STATUS | 6-ACTIVE |
MISCELLANEOUS INFORMATION/STATEMENTS |
|
| CHANGE IN REGISTRATION | NO |
FOREIGN INFORMATION |
|
| PRIORITY CLAIMED | SEC. 44(D) ON France |
| APPLICATION NO. | 4692947 |
| APPLICATION FILING DATE | 10/19/2020 |
| FOREIGN REG NO. | N/A |
| FOREIGN REG DATE | N/A |
| FOREIGN RNWL NUM | N/A |
| DATE OF FOREIGN RNWL | N/A |
| FOREIGN EXPIRATION | N/A |
| FOREIGN RNWL EXPIRATION | N/A |
PROSECUTION HISTORY |
||||
| DATE | ENT CD | ENT TYPE | DESCRIPTION | ENT NUM |
| 07/29/2021 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | 016 |
| 07/29/2021 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | 015 |
| 07/29/2021 | ALIE | A | ASSIGNED TO LIE | 014 |
| 07/26/2021 | ERSI | I | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | 013 |
| 02/16/2021 | GNS3 | O | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | 012 |
| 02/16/2021 | GNSL | S | LETTER OF SUSPENSION E-MAILED | 011 |
| 02/16/2021 | CNSL | R | SUSPENSION LETTER WRITTEN | 010 |
| 02/11/2021 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | 009 |
| 02/11/2021 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | 008 |
| 02/11/2021 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | 007 |
| 01/21/2021 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | 006 |
| 01/21/2021 | GNRT | F | NON-FINAL ACTION E-MAILED | 005 |
| 01/21/2021 | CNRT | R | NON-FINAL ACTION WRITTEN | 004 |
| 01/20/2021 | DOCK | D | ASSIGNED TO EXAMINER | 003 |
| 01/06/2021 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 002 |
| 11/10/2020 | NWAP | I | NEW APPLICATION ENTERED IN TRAM | 001 |
CURRENT CORRESPONDENCE INFORMATION |
|
| ATTORNEY | Karen Lim |
| CORRESPONDENCE ADDRESS | Karen Lim FROSS ZELNICK LEHRMAN & ZISSU, P.C. 151 WEST 42ND STREET, 17TH FLOOR NEW YORK, NY 10036 |
| DOMESTIC REPRESENTATIVE | Fross Zelnick Lehrman & Zissu, P.C. |